Upon scrutinizing the CCLE database, it was discovered that LMO2 is markedly expressed in ETP-ALL, yet more so in AML, thereby suggesting that LMO2 is selectively overexpressed in AML and may hold significant significance. Here, LMO2 is linked to acute myeloid leukemia.